STAT
SEPTEMBER 19, 2024
The priority review voucher bill would almost certainly need to ride with a larger package, such as appropriations legislation, and the unanimous vote by the House Energy and Commerce Committee increases the chances of the voucher program being renewed, at least temporarily, in a government stop-gap funding bill.
European Pharmaceutical Review
NOVEMBER 10, 2023
According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging. The construction projects will be finalised from the end of 2025 through to 2029. Most of the investment will be focused on API capacity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 15, 2022
For almost all their insulin, these companies manufacture the API and finished dose in-house and package the products themselves instead of using CMOs, GlobalData’s Drugs database shows. Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk.
Putting Patients First Blog
SEPTEMBER 30, 2024
3433 the Give Kids a Chance Act, which reauthorized the voucher program through 2029. With the funding deadline occurring after the November elections, the next round of negotiations will be impacted by the election results. Earlier this month, the House Energy and Commerce Committee unanimously passed H.R.
Pharmaceutical Technology
MARCH 7, 2023
Due to rising healthcare spending, launch of novel treatments, and the rise of chronic diseases in an aging population, the global pharmaceutical packaging equipment market is rapidly expanding. billion by 2029, registering a CAGR of over 8% during the forecast period of 2022-2029. Recent analysis valued the market [i] at USD 8.5
Expert insights. Personalized for you.
275 
Let's personalize your content